Skip to main content
Curative Biotechnology, Inc. (CUBT)
OTCMKTS: CUBT · Delayed Price · USD
0.0252
-0.0027 (-9.68%)
Apr 25, 2024, 11:12 AM EDT - Market closed

Curative Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Selling, General & Admin
1.954.214.6
Research & Development
2.480.78-
Operating Income
-4.44-5-4.6
Interest Expense
1.170.180.03
Other Expense / Income
0-0.17-0.03
Pretax Income
-5.6-5.34-4.67
Net Income
-5.6-5.34-4.67
Shares Outstanding (Basic)
57233
Shares Outstanding (Diluted)
57233
Shares Change
16848.72%-0.80%-
EPS (Basic)
-0.01-0.01-1.37
EPS (Diluted)
-0.01-0.01-1.37
Free Cash Flow
-1.61-1.63-0.22
Free Cash Flow Per Share
-0.00-0.48-0.07
EBITDA
-4.42-4.99-4.6
Depreciation & Amortization
0.010.010.01
EBIT
-4.43-5-4.6